Research

OBERON

An integrative strategy of testing systems for identification of EDs related to metabolic disorders

OBERON Project
Duration
01/01/2019 - 31/12/2023
Coordinator
Karine Audouze
Funded by
European Union’s Horizon 2020

Exposure to chemical substances that can produce endocrine disrupting effects represents one of the most critical public health threats nowadays. In line with the regulatory framework implemented within the European Union to reduce the levels of endocrine disruptors (EDs) for consumers, new and effective methods for ED testing are needed.

The OBERON project will build an integrated approach for testing and assessment (IATA) to detect endocrine disruptors-related metabolic disorders by developing, improving and validating a battery of test systems.

Total funding

€ 5,978,762

Our Team

Coordinator

  • Karine Audouze
    Karine Audouze

ISGlobal Team

Other projects

See Past Projects

EGG/EAGLE

Early Genetics Growth/Early Genetics and Lifecourse Epidemiology

APACHE

Air Pollution, Autism spectrum disorders, and brain imaging in CHildren amongst Europe

LIFECYCLE

Early-life stressors and LifeCycle health

HERA

Integrating Environment and Health Research: a Vision for the EU

ATHLETE

Advancing Tools for Human Early Lifecourse Exposome Research and Translation

MOOD-COVID

Pre- and post-natal Maternal mental health and newbOrn neurOdevelopment during the COVID-19 panDemic

EUCAN-Connect

A federated FAIR platform enabling large-scale analysis of high-value cohort data connecting Europe and Canada in personalized health